TrialPediatric blood & cancer2016

A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.

Peter M Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.